
Europe lifts restriction on Valneva’s chikungunya vaccine for elderly adults
(Reuters) -The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s chikungunya vaccine, Ixchiq, in adults aged 65 and above, following a safety review. The European Medicines Agency’s (EMA) safety …